Table 1

Genotype and allele frequencies of LBP-1c/CP2/LSF gene 3′ UTR polymorphism in patients with Alzheimer’s disease and non-demented age and sex matched controls

Age at onset and at collection (SD) (years)Genotype, n (frequency (95% CI))Allele, n (frequency (95% CI))
GGGAAAGA
CI, confidence interval; EAOD, early onset Alzheimer’s disease; LOAD, late onset Alzheimer’s disease; n, number of individuals genotyped.
All cases of Alzheimer’s disease (n = 166)67.6 (10.8)14719031319
(0.89 (0.93 to 0.84))(0.11 (0.16 to 0.07))(0.0 (0.0–))(0.94 (0.97 to 0.92))(0.06 (0.08 to 0.03))
All controls (n = 225)71.3 (11.4)216904419
(0.96 (0.99 to 0.93))(0.04 (0.07 to 0.01))(0.0 (0.0–))(0.98 (0.99 to 0.97))(0.02 (0.03 to 0.01))
LOAD (⩾70 years) (n = 95)76.1 (4.4)86901819
(0.91 (0.95 to 0.83))(0.9 (0.17 to 0.05))(0.0 (0.39 to 0.0))(0.95 (0.98 to 0.91))(0.05 (0.09 to 0.03))
Controls ⩾70 years (n = 193)77.8 (5.2)184903779
(0.95 (0.98 to 0.91))(0.05 (0.09 to 0.03))(0.0 (0.02 to 0.0))(0.98 (0.99 to 0.96))(0.02 (0.04 to 0.01))
EOAD (<70 years) (n = 71)61.5 (4.5)6110013210
(0.86 (0.92 to 0.76))(0.14 (0.24 to 0.08))(0.0 (0.05 to 0.0))(0.93 (0.96 to 0.88))(0.07 (0.13 to 0.04))
Controls <70 years (n = 32)64.1 (4.3)3200640
(1.0 (1.00 to 0.89))(0.0 (0.11 to 0.0))(0.0 (0.11 to 0.0))(1.0 (1.00 to 0.94))(0.0 (0.06 to 0.0))